University of South Carolina, Biochemistry, Ph.D., 2008
Clinical Interests
Drug discovery on lung cancer and mesothelioma treatment.
Research Interests
Drug discovery on lung cancer and mesothelioma
Biography
Yuyuan Dai joined Dr.Jablons's drug discovery team in 2013 as a junior specialist and then as a postdoctoral fellow. Her focus is mainly in drug screening and cancer related signaling pathway study. She has obtained her Ph.D. in Biochemistry from University of South Carolina in 2014 working with Dr. Wayne Outten on the Fe-S cluster pathway study. She has got her B.S. from Nanjing University in 2008.
Research Overview
Dr.Dai has focused his career on three important cancer-related areas: 1) small molecule kinase inhibitors screening 2) protein-protein interaction inhibitors screening 3) Druggable kinase discovery. Projects included in these areas include: Ck2 inhibitor screening, Hsp90-Cdc37 interaction inhibitor screening, Hippo pathway study in lung cancer and mesothelioma.